Physician profile
James M Kim
NPI 1316041726
$8,161.86
in general payments reported to CMS, 2019-2025
31 companies · $1,515 in 2025
The $1,515 reported for 2025 was more than what 96% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,352 · 2020: $608 · 2021: $530 · 2022: $1,506 · 2023: $842 · 2024: $1,809 · 2025: $1,515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,413 · Travel and Lodging: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,412.78 |
| Travel and Lodging | $753.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,980.75 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Abbvie INC. | $1,505.99 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $750.82 | 2019-2025 | Belbuca, Xtampza |
| Nevro Corp. | $713.38 | 2019-2020 | |
| Abbott Laboratories | $533.94 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $301.90 | 2022 | |
| Electronic Waveform Lab, INC. | $299.30 | 2019-2025 | |
| Pfizer INC. | $294.07 | 2023-2025 | |
| Biodelivery Sciences International, INC. | $263.17 | 2019-2021 | |
| Medtronic USA, INC. | $198.49 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $164.11 | 2021-2025 | Relistor |
| Sientra, INC. | $124.56 | 2022 | |
| Eisai INC. | $120.30 | 2020-2022 | |
| Almatica Pharma LLC | $120.10 | 2021-2023 | Gralise |
| Vertex Pharmaceuticals Incorporated | $101.55 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $95.00 | 2023-2024 | Quviviq |
| Mml US, INC. | $91.68 | 2025 | Reactiv8 |
| Boston Scientific Corporation | $72.11 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $71.34 | 2021 | |
| Integra Lifesciences Corporation | $63.50 | 2022 | |
| Scilex Pharmaceuticals INC. | $51.52 | 2022-2025 | |
| Heartflow, INC. | $47.51 | 2025 | |
| Si-Bone, INC. | $42.58 | 2020-2025 | |
| Convatec INC. | $31.95 | 2024 | |
| Globus Medical, INC. | $25.83 | 2025 | Senza |
| Daiichi Sankyo INC. | $24.20 | 2019 | |
| Baudax Bio INC. | $21.78 | 2020 | |
| Ibsa Pharma INC. | $18.18 | 2022 | |
| Redhill Biopharma INC. | $18.06 | 2023 | Talicia, Movantik, Aemcolo |
| Vertos Medical, INC. | $12.19 | 2020 | |
| Forte Bio-Pharma LLC | $2.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.